主办单位 主管单位 Atherosclerosis PlusPubMedESCISCIE中科院4区JCR:Q4 发文量282 被引量262 影响因子(2023)0.619 Atherosclerosis Plus is supported by the European Atherosclerosis Society. Atherosclerosis Plus publishes both original research and review papers that address the key aspects of atherosclerosis, inc...
Atherosclerosis Plus由Elsevier出版商出版,收稿方向涵盖PERIPHERAL VASCULAR DISEASE全领域,此期刊水平偏中等偏靠后,在所属细分领域中专业影响力一般,过审相对较易,如果您文章质量佳,选择此期刊,发表机率较高。平均审稿速度 11 Weeks ,影响因子指数1.4,该期刊近期没有被列入国际期刊预警名单,广大学者值得一试。中科院分区...
期刊网址:https://www.journals.elsevier.com/atherosclerosis-plus 出版商网址:http://www.elsevier.nl 简介 期刊简称ATHEROSCLEROSIS SUPP 参考译名《动脉粥样硬化+》 核心类别SCIE(2023版), 外文期刊, IF影响因子 自引率1.80% 主要研究方向医学-PERIPHERAL VASCULAR DISEASE 外周血管病 ...
影响因子(2023) 0.543Atherosclerosis brings together, from all sources, papers concerned with investigation on atherosclerosis, its risk factors and clinical manifestations. Atherosclerosis covers basic and translational, clinical and population research approaches to arterial and vascular biology and disease, ...